Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Ki-67 is a promising biomarker in breast cancer and the Ki-67 labeling index, or the percentage of Ki-67-positive cells, has great prognostic potential particularly in carcinomas of the breast. To overcome the challenges of manual calculation of ki67 proliferation index, in this project we will design and develop computational pathology and artificial intelligence (AI) algorithms to automate Ki67 quantification for tissue microarrays (TMA) and wholeslide images (WSI). AI can provide objective and efficient Ki67 scoring which would allow for more accurate diagnosis and turn-around times, which improves quality of care. Further, automation can be used to develop guidelines and standards for Ki67 scoring which will accelerate wide-scale clinical adoption.
April Khademi
Pathcore Inc
Engineering
Health and Related Sciences & Technology; Information and cultural industries
Toronto Metropolitan University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.